Summary
- Windtree (WINT) announced it plans to raise up to $200 million to invest in Binance Coin (BNB).
- Windtree stated it has already signed a $60 million stock purchase agreement with Build and Build Corp.
- Windtree explained that as the first Nasdaq-listed company to reserve BNB tokens, it can offer institutional investors an opportunity to access the Binance ecosystem.
Windtree Therapeutics (WINT), a Nasdaq-listed biotechnology company, has announced plans to raise up to $200 million to invest in Binance Coin (BNB).
According to GlobeNewswire on the 16th (local time), Windtree stated in a press release that it "plans to raise up to $200 million to reserve Binance Coin (BNB)" and has already "signed a stock purchase agreement worth $60 million with Build and Build Corp."
Windtree further commented, "We are the first Nasdaq-listed company to reserve BNB tokens," adding, "We can offer institutional investors seeking access to the Binance ecosystem an opportunity."
Son Min
sonmin@bloomingbit.ioHello I’m Son Min, a journalist at BloomingBit
![[Analysis] "XRP risks repeating the 2022 rout…most short-term investors in the red"](https://media.bloomingbit.io/PROD/news/845f37bb-29b4-4bc5-9e10-8cafe305a92f.webp?w=250)
![[Exclusive] “Airdrops also taxable”... Authorities to adopt a ‘comprehensive approach’ to virtual assets](https://media.bloomingbit.io/PROD/news/4bde9dab-09bd-4214-a61e-f6dbf5aacdfb.webp?w=250)